
Regeneron Pharmaceuticals (REGN) Latest News & Updates
Explore latest Regeneron Pharmaceuticals (REGN) News and Updates
Stay updated on Regeneron Pharmaceuticals (REGN) with the latest news, market trends, and key developments to support informed investing decisions.
Start investing in Regeneron Pharmaceuticals (REGN)
Order type
Buy in
Order amount
Est. shares
0 shares
InvestorPlace •


GlobeNewsWire •

GlobeNewsWire •

GlobeNewsWire •

The Motley Fool •

Press Release: Japan first in the world to approve Dupixent® for chronic spontaneous urticaria (CSU)
GlobeNewsWire •

GlobeNewsWire •

Seeking Alpha •



The Motley Fool •

Zacks Investment Research •

Seeking Alpha •


Zacks Investment Research •

Investors Business Daily •

Zacks Investment Research •



GlobeNewsWire •

InvestorPlace •

Zacks Investment Research •


